Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Beta-blocker Uptitration in Heart Failure Patients Receiving Cardiac Resynchronization Therapy With Optivol Fluid Status Monitoring System

NCT00433043 is registered in ClinicalTrials.gov with St. Luke's-Roosevelt Hospital Center as lead sponsor.

NCT NCT00433043
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00433043 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Beta-blocker Uptitration in Heart Failure Patients Receiving Cardiac Resynchronization Therapy With Optivol Fluid Status Monitoring System
Lead sponsor
St. Luke's-Roosevelt Hospital Center
Phase
Phase 4
Overall status
Terminated
Start date
January 31, 2007
Completion date
May 31, 2009
Enrollment
2 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

congestive heart failure